FDA Approves Generic Xofluza
The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
The FDA approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.
Read MoreUnderlying chronic conditions and hospital transfers are major indicators of severe disease in pediatric patients with respiratory tract infections.
Read MoreResearchers found that sialidase inhibitors—a class of flu drugs including oseltamivir (Tamiflu)—protected against degradation of protective sugar molecules tied to cognitive decline and premature aging in people living with HIV.
Read MoreFor every 100 children vaccinated against influenza, between nine and 14 cases are prevented, according to Harvard Medical School data.
Read MoreA veterinary professional showed serologic evidence of H5N1 avian influenza infection after exposure to an ill cat, the CDC reports.
Read MoreResearchers developed an avian flu vaccine platform that generates immunity in the respiratory tract and bloodstream to combat H5N1.
Read MoreVertical ventilation ducts in residential buildings can facilitate the spread of infectious respiratory aerosols in multi-family buildings.
Read MoreThe once-weekly INNA-051 treatment from ENA Respiratory aims to prime the immune system to protect high-risk patients from influenza, RSV, and other respiratory viruses.
Read MoreA study of Northern Hemisphere waterfowl suggests that environmental diversity and human activity significantly impact the transmission of H5N1.
Read MoreNew research indicates that influenza D replicates in human respiratory tissue as effectively as influenza A, raising concerns about potential zoonotic transmission.
Read MoreDefense secretary Pete Hegseth cited medical autonomy and religious freedom in the decision to drop the long-standing flu vaccine mandate.
Read MoreAn NFID initiative provided evidence-based guidance on influenza, COVID-19, and RSV during the 2025-2026 season.
Read MoreA new whitepaper shows that real-time clinical insights for primary care physicians led to higher flu vaccination rates and fewer emergency visits for high-risk populations, including COPD patients.
Read MoreAn infection in Italy marks the first European case of the H9N2 avian influenza strain. Experts indicate the current risk to the public remains low.
Read MoreA new project funded by the US Department of Agriculture investigates how nonthermal plasma can inactivate airborne viruses to protect workers and livestock.
Read MoreThe new Roche diagnostic test identifies 25 viruses and bacteria to help clinicians provide...
Read MoreResearchers created a machine-learning–based index to map states’ vulnerability to influenza-like illness using 39 socioeconomic and health indicators.
Read MoreResearchers say tens of thousands of black vultures have likely contracted or died from the avian flu virus.
Read MoreThe influenza A virus exploits specific immune cells to infiltrate the heart and damage heart muscle cells.
Read MoreResearchers warn that canine coronavirus, which has been linked to human respiratory illness in Southeast Asia, and influenza D, commonly found in cows, deserve closer monitoring to prevent future human outbreaks.
Read MoreVaccination against influenza and COVID-19 currently lags among people 50 and older, according to a national survey.
Read MoreThe 2026 AAP recommendations remain largely unchanged from 2025 but differ from the CDC’s new immunization schedule.
Read MoreWhile repeated flu vaccination may reduce the initial antibody surge, it does not substantially lower antibody levels later in the season.
Read MoreWUSTL researchers developed an intranasal avian flu vaccine that elicited strong immune responses when tested in hamsters and mice and prevented infections in exposed animals.
Read More